GlassScriptPhysician profile
Jim D Crowley
NPI 1083697957
$7,855.39
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $713 · 2020: $345 · 2021: $263 · 2022: $706 · 2023: $5,829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Travel and Lodging: $1,274 · Food and Beverage: $54.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Travel and Lodging | $1,273.69 |
| Food and Beverage | $54.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,361.05 | 2022-2023 | Davinci Xi, Da Vinci Surgical System, Da Vinci Sp |
| Boston Scientific Corporation | $1,056.92 | 2019-2022 | |
| 180 Medical, INC. | $94.02 | 2019-2020 | |
| Astellas Pharma US INC | $92.34 | 2019-2022 | |
| Pfizer INC. | $65.35 | 2019-2020 | |
| Janssen Biotech, INC. | $49.11 | 2019 | |
| Dendreon Pharmaceuticals LLC | $42.47 | 2019 | |
| Abbvie INC. | $19.67 | 2020 | |
| Coloplast Corp | $18.43 | 2019 | |
| Urogen Pharma, INC. | $14.50 | 2022 | |
| Axonics, INC. | $14.04 | 2021 | |
| Allergan, INC. | $11.99 | 2019 | |
| Merck Sharp & Dohme LLC | $11.68 | 2019 | |
| Travere Therapeutics, INC. | $3.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jim Crowley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.